fentanyl and pectins

fentanyl has been researched along with pectins in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.88)29.6817
2010's15 (88.24)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Smith, A; Watts, P1
Fisher, A; Knight, A; Smith, A; Watling, M2
Ellershaw, JE; Gatti, A; Luis Lerzo, G; Radbruch, L; Revnic, J; Taylor, D; Torres, LM1
Gouliamos, A; Mystakidou, K; Panagiotou, I1
Lyseng-Williamson, KA1
Bulloch, MN; Hutchison, AM1
Knight, A; Perelman, M1
Ellershaw, JE; Perelman, M; Radbruch, L; Revnic, J; Taylor, D; Torres, LM1
Adile, C; Casuccio, A; Mercadante, S; Prestia, G1
Bergamini, C; Bossi, P; Granata, R; Imbimbo, M; Licitra, L; Locati, L; Mirabile, A; Resteghini, C1
Benitez, D; Calderón, E; Perelman, M; Torres, LM; Trinidad, JM1
Adile, C; Aielli, F; Casuccio, A; Costanzi, A; Mercadante, S1
Bruera, E; Hui, D; Kilgore, K; Liu, D; Park, M; Williams, J1
Albanese, S; Alongi, F; Fersino, S; Fiorentino, A; Giaj-Levra, N; Gori, S; Mazzola, R; Ricchetti, F; Tebano, U1
Garcia, AJ; Luna, J; Marin, JP; Olivera, J; Pardo, J; Perez, AM; Prieto, I1
Baudrant, M; Bedouch, P; Cracowski, JL; Drevet, S; Gavazzi, G; Gibert, P; Grevy, A; Maindet, C; Maljean, L; Mitha, N; Payen, M; Tiffet, T; Zerhouni, N1

Reviews

3 review(s) available for fentanyl and pectins

ArticleYear
PecSys: in situ gelling system for optimised nasal drug delivery.
    Expert opinion on drug delivery, 2009, Volume: 6, Issue:5

    Topics: Administration, Intranasal; Animals; Buprenorphine; Clinical Trials as Topic; Dosage Forms; Drug Delivery Systems; Fentanyl; Gels; Humans; Pectins; Technology, Pharmaceutical

2009
Fentanyl nasal spray for the treatment of cancer pain.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:10

    Topics: Administration, Intranasal; Administration, Oral; Analgesics, Opioid; Drug Delivery Systems; Fentanyl; Humans; Nasal Sprays; Neoplasms; Pain; Pectins

2011
Fentanyl pectin nasal spray: in breakthrough pain in opioid-tolerant adults with cancer.
    CNS drugs, 2011, Jun-01, Volume: 25, Issue:6

    Topics: Analgesics, Opioid; Drug Tolerance; Fentanyl; Humans; Nasal Sprays; Neoplasms; Pain; Pectins

2011

Trials

8 trial(s) available for fentanyl and pectins

ArticleYear
Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:2

    Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Area Under Curve; Biological Availability; Chitosan; Cross-Over Studies; Excipients; Female; Fentanyl; Humans; Male; Middle Aged; Pectins; Poloxamer; Young Adult

2010
Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 - 800 µg in healthy volunteers.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:12

    Topics: Adult; Analgesics, Opioid; Area Under Curve; Biological Availability; Cross-Over Studies; Female; Fentanyl; Humans; Male; Middle Aged; Nasal Sprays; Pectins

2010
A pharmacokinetic assessment of an alternate titration strategy for fentanyl pectin nasal spray.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:12

    Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Cross-Over Studies; Female; Fentanyl; Humans; Male; Pectins

2013
A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
    Journal of pain and symptom management, 2014, Volume: 47, Issue:6

    Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Drug Combinations; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Nasal Sprays; Neoplasms; Palliative Care; Pectins; Time Factors; Young Adult

2014
Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
    The journal of pain, 2014, Volume: 15, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthrough Pain; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Male; Middle Aged; Nasal Sprays; Neoplasms; Pain Measurement; Pectins

2014
Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
    Journal of pain and symptom management, 2016, Volume: 52, Issue:1

    Topics: Administration, Oral; Analgesics; Breakthrough Pain; Cancer Pain; Cross-Over Studies; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Nasal Sprays; Pain Measurement; Pectins; Treatment Outcome

2016
Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
    Journal of pain and symptom management, 2016, Volume: 52, Issue:4

    Topics: Administration, Intranasal; Analgesics, Opioid; Double-Blind Method; Dyspnea; Exercise; Female; Fentanyl; Humans; Male; Middle Aged; Nasal Sprays; Neoplasms; Pectins; Pilot Projects; Severity of Illness Index; Treatment Outcome; Walk Test

2016
Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning.
    Scandinavian journal of pain, 2016, Volume: 11

    Topics: Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Fentanyl; Humans; Nasal Sprays; Pectins; Radiotherapy

2016

Other Studies

6 other study(ies) available for fentanyl and pectins

ArticleYear
Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:3

    Topics: Absorption; Administration, Intranasal; Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Nasal Mucosa; Nasal Sprays; Neoplasms; Pain Measurement; Patient Satisfaction; Pectins

2012
Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain.
    Expert review of clinical pharmacology, 2013, Volume: 6, Issue:1

    Topics: Administration, Intranasal; Analgesics, Opioid; Dose-Response Relationship, Drug; Drug Carriers; Fentanyl; Humans; Nasal Sprays; Neoplasms; Pain; Pectins; Randomized Controlled Trials as Topic

2013
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
    Oral oncology, 2014, Volume: 50, Issue:9

    Topics: Administration, Inhalation; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Combined Modality Therapy; Female; Fentanyl; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pectins; Stomatitis

2014
Fentanyl pectin nasal spray for breakthrough cancer pain.
    International journal of palliative nursing, 2015, Volume: 21, Issue:3

    Topics: Administration, Intranasal; Analgesics, Opioid; Breakthrough Pain; Fentanyl; Humans; Neoplasms; Pectins

2015
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antineoplastic Agents; Breakthrough Pain; Cisplatin; Female; Fentanyl; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Nasal Sprays; Pain Management; Pectins; Radiotherapy, Intensity-Modulated; Retrospective Studies

2017
Tolerance of Fentanyl Pectin Nasal Spray for Procedural Pain in Geriatric Patients.
    Journal of the American Medical Directors Association, 2022, Volume: 23, Issue:6

    Topics: Aged; Analgesics, Opioid; Drug-Related Side Effects and Adverse Reactions; Fentanyl; Humans; Nasal Sprays; Neoplasms; Pain, Procedural; Pectins; Prospective Studies

2022